PLAU and prostate cancer: In addition, in prostate cancer cells TGF-β1 stimulates the expression and activity of uPA, PAI-1, and MMP-9, resulting in a net increment of pericellular plasminogen activation, increased activation of MMP-9, and finally increased tumour cell invasion and metastasis [9, 10].